Covered recipient · General Payments record
GWENDOLINE FONEBI
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2022–2024
$443.61
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $182.43 | 10 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $99.00 | 1 |
| ABBVIE INC. | $42.13 | 2 |
| GlaxoSmithKline, LLC. | $40.32 | 2 |
| Celgene Corporation | $36.03 | 2 |
| PFIZER INC. | $32.35 | 2 |
| GENZYME CORPORATION | $15.80 | 1 |
| Agios Pharmaceuticals, Inc. | $15.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.31 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103740725 | CMS |
| ABBVIE INC. | $19.82 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103740727 | CMS |
| Agios Pharmaceuticals, Inc. | $15.80 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149646340 | CMS |
| Celgene Corporation | $18.35 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101125810 | CMS |
| Celgene Corporation | $17.68 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101125826 | CMS |
| Exelixis Inc. | $99.00 | 04/09/2024 | Education | Undisputed | 01/23/2026 | 1138558290 | CMS |
| GENZYME CORPORATION | $15.80 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139810874 | CMS |
| GlaxoSmithKline, LLC. | $21.27 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116550275 | CMS |
| GlaxoSmithKline, LLC. | $19.05 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116527130 | CMS |
| PFIZER INC. | $15.10 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131350802 | CMS |
| PFIZER INC. | $17.25 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131900789 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.